SQ Innovation Launches Lasix® ONYU for Home Treatment of Heart Failure Patients SQ Innovation has announced the launch of Lasix® ONYU, a groundbreaking treatment for heart failure patients, accessible through major U.S. distributors, enabling at-home care.

SQ Innovation Launches Lasix® ONYU for Home Treatment of Heart Failure Patients #USA #Burlington #Heart_Failure #Lasix_ONYU #SQ_Innovation

SQ Innovation AG Welcomes New Leadership and Secures Funding for Lasix ONYU Launch SQ Innovation AG announces the appointment of two new board members and successfully closes its Series B financing for Lasix ONYU in the U.S.

SQ Innovation AG Welcomes New Leadership and Secures Funding for Lasix ONYU Launch #Switzerland #Heart_Failure #Zug #Lasix_ONYU #SQ_Innovation

SQ Innovation's Lasix® ONYU Receives FDA Nod for Heart Failure Edema Treatment SQ Innovation's FDA approval of Lasix® ONYU marks a pivotal advance in treating chronic heart failure-related edema, bringing at-home therapy options to patients.

SQ Innovation's Lasix® ONYU Receives FDA Nod for Heart Failure Edema Treatment #United_States #FDA_Approval #Burlington #Lasix_ONYU #SQ_Innovation

Gerresheimer's Lasix ONYU Receives FDA Tentative Approval for Innovative Home Treatment Gerresheimer's Lasix ONYU, an innovative product for heart failure treatment, gains FDA Tentative Approval, enhancing remote patient care.

Gerresheimer's Lasix ONYU Receives FDA Tentative Approval for Innovative Home Treatment #Germany #FDA_Approval #Düsseldorf #Gerresheimer #Lasix_ONYU